Add To Watchlist
Share URL
About The Company
CEO
Mr. Thomas E. Polen Jr.
Market Cap
67.64 Billion USD
Sector
Healthcare
Website
https://www.bd.comLast Update
2/22/2024, 12:00:00 PM
Description
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide.
Read More
Overview
Value
24
Growth
48
Health
72
Management
72
Analyst Opinion
89
Total
61
All Scores Out Of 100
Best Features
- Has a low level of debt
- Has strong financial health
- Liked by analysts
- Very safe dividend
Risk Factors
- Earnings have declined recently
- There is a history of diluting shareholders
- No margin of safety at their current market price
- Disliked by Twitter users
- Price-to-earnings ratio of 53.8 is higher than the market average (19.6x)
- High preportion of income is paid as dividend
Market Peers
BDX
Key Figures
PE Ratio (TTM)
53.78
Margin Of Safety (DCF)
-3.75%
Revenue Growth (5 Year Average)
11.92%
Ratings Consensus
Strong Buy
Share Buybacks
-5.73%
Dividend Yeild (TTM)
1.63%
Valuation
Value Score
24
Desired Margin Of Safety
0%
▼
Tip: Set your desired Margin Of Safety
Free Cash Flow Type
Annual Cashflow Growth
0%
Discount Rate
0%
Buy Target: < 183.8 USD ✘
Current Price: 235.6 USD
How Does This Work?
Show Advanced Options
This calculator helps investors estimate the Intrinsic Value of a company based on the current value of future cash flows. To use the tool, simply input a desired Margin Of Safety, which is an additional discount applied to the present value of the expected future cash flows. The tool calculates the present value using a discount rate that reflects the risk and time value of money, and provides an estimated target price for the company based on the selected margin of safety. The calculator defaults to using 5 Year Free Cash Flow Growth % and a discount rate based on the US 10-year treasury bond coupon rate. Use our performance analyser to get a feel the impact this has on longterm investment returns and discover a margin of safety you are comfortable with. This can be a useful tool for investors looking to make informed decisions about whether to buy or sell shares of a particular company.
Price/Earnings
53.78x
Free Cashflow Yeild
3.89%
PE/Earnings Growth
N/A
Price/Book
2.69x
Growth
Growth Score
48
- ✔ 5 Year Average Revenue growth of 11.92% is higher than the market average (10.97%)
- ✔ 5 Year Average Cashflow growth of 15.55% is higher than the market average (12.35%)
- ✔ Free Cashflow growth has improved this year
- ✘ Revenue growth has slowed this year
- ✘ 5 Year Average Earnings growth of 4.59% is lower than the market average (14.48%)
- ✘ Earnings growth has slowed this year
Revenue Growth
11.92%
Earnings Growth
4.59%
Cashflow Growth
15.55%
Health
Health Score
72
Altman Z Score
2.43
Piostroski Score
7.00
Debt/Equity
0.58x
Current Assets/Liabilities
1042.25x
Free Cashflow/Total Debt
0.10x
Debt/Capital
1.81x
Dividend
Secure Dividend Score
71
- ✔ Very safe
- ✔ Dividends have shown growth over the last 5 years
- ✔ Spending a lower percentage of their income on dividends than last 5 years
- ✘ Dividend yeild of 1.63% is less than the market average (1.85%)
- ✘ Long term dividend payout ratio of 112.18% is high and may limit growth
- ✘ Payout ratio (TTM) of 88.22% is higher than the average (40%)
- ✘ Dividend growth has been slowing recently
Dividend Yeild
1.63%
Dividend Growth
3.24%
Payout Ratio (Earnings)
88.22%
Payout Ratio (Cashflow)
41.84%
Management
Management Score
72
- ✔ Has issued new shares to finance growth when share price is high
- ✔ Has returned higher dividends when earnings have risen
- ✔ Return-on-capital-employed of 12.54% is higher than the market average (10%)
- ✘ Has a history of diluting shareholders to finance activity
- ✘ Return-on-equity of 6.45% is lower than the market average (15%)
Average Buybacks/Dilution
-5.73%
Recent Buybacks/Dilution
-0.13%
5 Year Price Volitility
5.76%
Return On Assets
3.08%
Return On Capital Employed
12.54%
Return On Equity
6.45%
Return On Free Cashflow
N/A
Return On Investments
N/A
Analysts
Analyst Opinion
89
- ✔ Ratings consensus is Strong Buy
SEC Filings
Find yearly (10-K), quaterly (10-Q) and disclosure (8-K) report here, on the Securities and Exchange Commission's EDGAR database. If reading through reports isn't your cup of tea, don't worry. We've made it easy for you by summarizing all the important bits.
Other Information
Company Name
Becton, Dickinson and Company
Currency
USD
Beta
0.588797
Vol Avg
1118018
Ceo
Mr. Thomas E. Polen Jr.
Cik
0000010795
Cusip
075887109
Exchange
New York Stock Exchange
Full Time Employees
77000
Industry
Medical Instruments & Supplies
Sector
Healthcare
Ipo Date
1973-02-21
Address
1 Becton Drive
City
Franklin Lakes
State
NJ
Country
US
Zip
07417-1880
Phone
201 847 6800
Analysis Last Updated
2/22/2024, 12:00:00 PM
All financial data provided by FMP
Social Sentiment
Social Sentiment Score
0
Twitter Sentiment
N/A
Stocktwits Sentiment
N/A